NovaBay Pharmaceuticals, Inc. (NYSE:NBY) is a biopharmaceutical company specializing in anti-infective therapies for ...
MindWalk Holdings Corp. (NASDAQ:HYFT), formerly ImmunoPrecise Antibodies, is a Bio-Native AI company combining artificial ...
Discover why Regeneron (REGN) is a top investment pick with strong Dupixent growth, a robust pipeline, and lasting potential.
The American pharmaceutical giant Pfizer announced on Monday the acquisition of the biotechnology company Metsera for at ...
Biotech stocks are flashing risk-on. The SPDR S&P Biotech ETF has outperformed the broader Health Care Select Sector SPDR Fund and S&P 500 over the last three months. The biotech ETF is making a run ...
Zacks Investment Research on MSN
CRMD vs. MIRM: Which Specialized Biotech Stock is the Better Pick?
CorMedix CRMD and Mirum Pharmaceuticals MIRM are pursuing treatments for underserved medical conditions where existing ...
A $600,000 allocation from Oklahoma City's economic development fund is being sought for construction of a new $46.7 million medical research lab.
Extremophiles, microorganisms that thrive in extreme environmental conditions, possess unique biochemical and physiological traits that make them valuable for various industrial applications. These ...
Harbor Capital Advisors shares Q2 updates on its Health Care ETF, spotlighting biotech gains, policy risks, and M&A potential ...
A new training space for future biopharmaceutical employees is now operational at the Pitt County Technology Enterprise ...
Two relatively unknown biotechs that are developing promising therapies in this field are Terns Pharmaceuticals ( TERN -7.64%) and Rhythm Pharmaceuticals ( RYTM -2.57%). These biotechs could soar ...
Malvern biotech company Ocugen signed a deal for its experimental gene therapy with Kwangdong Pharmaceutical to bring in over $25 million.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback